The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorder.

Abstract

BACKGROUND Co-morbidity may influence GPs' treatment decisions for patients with anxiety. However, knowledge about differences in the pharmacological treatment of anxiety disorders in patients with and without co-morbidity is lacking. OBJECTIVE To compare GPs' pharmacological treatment patterns for anxiety in patients with and without co-morbidity… (More)

Topics

  • Presentations referencing similar topics